FR2893941B1 - NOVEL 2,4-DIANILINOPYRIDINE DERIVATIVES, THEIR PREPARATION AS MEDICAMENTS, PHARMACEUTICAL COMPOSITIONS AND IN PARTICULAR AS INHIBITORS OF IKK - Google Patents

NOVEL 2,4-DIANILINOPYRIDINE DERIVATIVES, THEIR PREPARATION AS MEDICAMENTS, PHARMACEUTICAL COMPOSITIONS AND IN PARTICULAR AS INHIBITORS OF IKK

Info

Publication number
FR2893941B1
FR2893941B1 FR0511950A FR0511950A FR2893941B1 FR 2893941 B1 FR2893941 B1 FR 2893941B1 FR 0511950 A FR0511950 A FR 0511950A FR 0511950 A FR0511950 A FR 0511950A FR 2893941 B1 FR2893941 B1 FR 2893941B1
Authority
FR
France
Prior art keywords
dianilinopyridine
ikk
medicaments
inhibitors
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0511950A
Other languages
French (fr)
Other versions
FR2893941A1 (en
Inventor
Michael Bosch
Monsif Bouaboula
Pierre Casellas
Samir Jegham
Jean Flaubert Nguefack
Jean Wagnon
Bernard Tonnerre
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis France
Original Assignee
Sanofi Aventis France
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR0511950A priority Critical patent/FR2893941B1/en
Application filed by Sanofi Aventis France filed Critical Sanofi Aventis France
Priority to BRPI0613452-1A priority patent/BRPI0613452A2/en
Priority to EP06778795A priority patent/EP1904479A2/en
Priority to CA002614597A priority patent/CA2614597A1/en
Priority to KR1020087000779A priority patent/KR20080027832A/en
Priority to NZ564872A priority patent/NZ564872A/en
Priority to MX2008000574A priority patent/MX2008000574A/en
Priority to JP2008520910A priority patent/JP2009501711A/en
Priority to PCT/FR2006/001619 priority patent/WO2007006926A2/en
Priority to EA200800285A priority patent/EA200800285A1/en
Priority to AU2006268531A priority patent/AU2006268531A1/en
Publication of FR2893941A1 publication Critical patent/FR2893941A1/en
Priority to TNP2007000471A priority patent/TNSN07471A1/en
Priority to CR9602A priority patent/CR9602A/en
Priority to EC2007008064A priority patent/ECSP078064A/en
Priority to IL188494A priority patent/IL188494A0/en
Priority to US11/971,389 priority patent/US20080269170A1/en
Priority to NO20080456A priority patent/NO20080456L/en
Priority to MA30603A priority patent/MA29649B1/en
Publication of FR2893941B1 publication Critical patent/FR2893941B1/en
Application granted granted Critical
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
FR0511950A 2005-07-11 2005-11-25 NOVEL 2,4-DIANILINOPYRIDINE DERIVATIVES, THEIR PREPARATION AS MEDICAMENTS, PHARMACEUTICAL COMPOSITIONS AND IN PARTICULAR AS INHIBITORS OF IKK Expired - Fee Related FR2893941B1 (en)

Priority Applications (18)

Application Number Priority Date Filing Date Title
FR0511950A FR2893941B1 (en) 2005-11-25 2005-11-25 NOVEL 2,4-DIANILINOPYRIDINE DERIVATIVES, THEIR PREPARATION AS MEDICAMENTS, PHARMACEUTICAL COMPOSITIONS AND IN PARTICULAR AS INHIBITORS OF IKK
EA200800285A EA200800285A1 (en) 2005-07-11 2006-07-06 NEW DERIVATIVES 2,4-DIANILINOPIRIMIDINES, THEIR PRODUCTION, MEDICINES, PHARMACEUTICAL COMPOSITIONS, CONTAINING INDICATED DERIVATIVES, AND THEIR APPLICATION, IN PARTICULAR, AS THE PROTECTIVE.
EP06778795A EP1904479A2 (en) 2005-07-11 2006-07-06 Novel 2,4-dianilinopyrimidine derivatives, the preparation thereof, their use as medicaments, pharmaceutical compositions and, in particular, as ikk inhibitors
KR1020087000779A KR20080027832A (en) 2005-07-11 2006-07-06 Novel 2,4-dianilinopyrimidine derivatives, the preparation thereof, their use as medicaments, pharmaceutical compositions and, in particular, as ikk inhibitors
NZ564872A NZ564872A (en) 2005-07-11 2006-07-06 Novel 2,4-dianilinopyrimidine derivatives, the preparation thereof, their use as medicaments, pharmaceutical compositions and, in particular, as ikk inhibitors
MX2008000574A MX2008000574A (en) 2005-07-11 2006-07-06 Novel 2,4-dianilinopyrimidine derivatives, the preparation thereof, their use as medicaments, pharmaceutical compositions and, in particular, as ikk inhibitors.
JP2008520910A JP2009501711A (en) 2005-07-11 2006-07-06 Novel 2,4-dianilinopyrimidine derivatives, their preparation, pharmaceuticals, their use as pharmaceutical compositions, in particular as IKK inhibitors
PCT/FR2006/001619 WO2007006926A2 (en) 2005-07-11 2006-07-06 Novel 2,4-dianilinopyrimidine derivatives, the preparation thereof, their use as medicaments, pharmaceutical compositions and, in particular, as ikk inhibitors
CA002614597A CA2614597A1 (en) 2005-07-11 2006-07-06 Novel 2,4-dianilinopyrimidine derivatives, the preparation thereof, their use as medicaments, pharmaceutical compositions and, in particular, as ikk inhibitors
AU2006268531A AU2006268531A1 (en) 2005-07-11 2006-07-06 Novel 2,4-dianilinopyrimidine derivatives, the preparation thereof, their use as medicaments, pharmaceutical compositions and, in particular, as IKK inhibitors
BRPI0613452-1A BRPI0613452A2 (en) 2005-07-11 2006-07-06 2,4-dianilino pyrimidines derivatives, their preparation as pharmaceuticals, pharmaceutical compositions and notably as ikk inhibitors
TNP2007000471A TNSN07471A1 (en) 2005-07-11 2007-12-14 Novel 2,4 - dianilinopyrimidine derivatives, the preparation thereof, their use as medicaments, pharmaceutical compositions and, in particular, as ikk inhibitors
CR9602A CR9602A (en) 2005-07-11 2007-12-18 NEW DERIVATIVES OF 2,4-DIANILINPIRIMIDINAS, ITS PREPARATION, AS MEDICINES, PHARMACEUTICAL COMPOSITIONS AND PARTICULARLY AS IKK INHIBITORS
EC2007008064A ECSP078064A (en) 2005-07-11 2007-12-28 NEW DERIVATIVES OF 2,4-DIANILINOPIRIMIDINAS, ITS PREPARATION, AS MEDICINES, PHARMACEUTICAL COMPOSITIONS AND MAINLY AS IKK INHIBITORS
IL188494A IL188494A0 (en) 2005-07-11 2007-12-30 Novel 2,4-dianlinopyrimidine derivatives, the preparation thereof, their use as medicaments, pharmaceutical compositions and, in particular, as ikk inhibitors
US11/971,389 US20080269170A1 (en) 2005-07-11 2008-01-09 Novel 2,4-Dianilinopyrimidine Derivatives, the Preparation Thereof, Their Use as Medicaments, Pharmaceutical Compositions and, in Particular, as IKK Inhibitors
NO20080456A NO20080456L (en) 2005-07-11 2008-01-24 Novel 2,4-dianilinopyrimidine derivatives, their preparation and their use as drugs, pharmaceutical compositions and, in particular, as IKK inhibitors
MA30603A MA29649B1 (en) 2005-07-11 2008-01-28 NOVEL 2,4-DIANILINOPYRIMIDINE DERIVATIVES, THEIR PREPARATION AS MEDICAMENTS, PHARMACEUTICAL COMPOSITIONS AND IN PARTICULAR AS INHIBITORS OF IKK

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0511950A FR2893941B1 (en) 2005-11-25 2005-11-25 NOVEL 2,4-DIANILINOPYRIDINE DERIVATIVES, THEIR PREPARATION AS MEDICAMENTS, PHARMACEUTICAL COMPOSITIONS AND IN PARTICULAR AS INHIBITORS OF IKK

Publications (2)

Publication Number Publication Date
FR2893941A1 FR2893941A1 (en) 2007-06-01
FR2893941B1 true FR2893941B1 (en) 2009-06-05

Family

ID=36676073

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0511950A Expired - Fee Related FR2893941B1 (en) 2005-07-11 2005-11-25 NOVEL 2,4-DIANILINOPYRIDINE DERIVATIVES, THEIR PREPARATION AS MEDICAMENTS, PHARMACEUTICAL COMPOSITIONS AND IN PARTICULAR AS INHIBITORS OF IKK

Country Status (1)

Country Link
FR (1) FR2893941B1 (en)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2274634T3 (en) * 1998-08-29 2007-05-16 Astrazeneca Ab PIRIMIDINE COMPOUNDS.
GB0004888D0 (en) * 2000-03-01 2000-04-19 Astrazeneca Uk Ltd Chemical compounds
WO2003030909A1 (en) * 2001-09-25 2003-04-17 Bayer Pharmaceuticals Corporation 2- and 4-aminopyrimidines n-substtituded by a bicyclic ring for use as kinase inhibitors in the treatment of cancer

Also Published As

Publication number Publication date
FR2893941A1 (en) 2007-06-01

Similar Documents

Publication Publication Date Title
FR2911138B1 (en) NOVEL N, N'-2,4-DIANILINOPYRIMIDINE DERIVATIVES, THEIR PREPARATION AS MEDICAMENTS, PHARMACEUTICAL COMPOSITIONS AND IN PARTICULAR AS INHIBITORS OF IKK
FR2911137B1 (en) NOVEL 2,4-DIANILINOPYRIMIDE DERIVATIVES, THEIR PREPARATION AS MEDICAMENTS, PHARMACEUTICAL COMPOSITIONS AND IN PARTICULAR AS INHIBITORS OF IKK
FR2911140B1 (en) NOVEL 2-ANILINO 4-HETEROARYL PYRIMIDES DERIVATIVES, THEIR PREPARATION AS MEDICAMENTS, PHARMACEUTICAL COMPOSITIONS, AND IN PARTICULAR AS INHIBITORS OF IKK
FR2919869B1 (en) NOVEL N, N'-2,4-DIANILINOPYRIMIDINE DERIVATIVES, THEIR PREPARATION AS MEDICAMENTS, PHARMACEUTICAL COMPOSITIONS AND IN PARTICULAR AS INHIBITORS OF IKK
FR2847253B1 (en) NOVEL DERIVATIVES OF PYRIDAZINONES AS MEDICAMENTS AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEM
MA28732B1 (en) NOVEL CYCLIC UREA DERIVATIVES, THEIR PREPARATION, AND THEIR PHARMACEUTICAL USE AS INHIBITORS OF KINASE
IL188494A0 (en) Novel 2,4-dianlinopyrimidine derivatives, the preparation thereof, their use as medicaments, pharmaceutical compositions and, in particular, as ikk inhibitors
IL221770A (en) Adamantyl-acetamide derivatives, pharmaceutical compositions comprising same and use thereof for preparation of medicaments
MA27392A1 (en) NOVEL AMINOINDAZOLES DERIVATIVES AS MEDICAMENTS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
ITFI20050042A1 (en) N-HYDROXYAMIDES - SUBSTITUTED WITH TRICYCLIC GROUPS AS INHIBITORS OF THE ISLANDS DEACELITASIS, THEIR PREPARATION AND USE IN PHARMACEUTICAL FORMULATIONS
FR2818642B1 (en) NOVEL DERIVATIVES OF PURINE, PROCESS FOR PREPARING THEM, THEIR USE AS MEDICAMENTS, PHARMACEUTICAL COMPOSITIONS AND THEIR NEW USE
EA200801998A1 (en) ПИРДДИН [3,4-b] ПИРАЗИНОНЫ
BRPI0508263B8 (en) 1, 2, 3,4-tetrahydro-isoquinoline derivatives, pharmaceutical composition, and use of 1, 2, 3,4-tetrahydro-isoquinoline derivative
EE200300207A (en) Heterocyclylalkylpiperidine Derivatives, Methods of Preparation, and Pharmaceutical Composition
FR2896504B1 (en) NOVEL CYCLIC UREA DERIVATIVES, THEIR PREPARATION AND THEIR PHARMACEUTICAL USE AS INHIBITORS OF KINASES
FR2862647B1 (en) PYRAZOLYL DERIVATIVES, PREPARATION METHOD AND INTERMEDIATES THEREOF AS MEDICAMENTS AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME
BRPI0514843A (en) pyrrolo [3,2-c] pyridine derivatives and processes for their preparation
FR2854159B1 (en) NOVEL INDOLE DERIVATIVES, THEIR PREPARATION AS MEDICAMENTS, PHARMACEUTICAL COMPOSITIONS AND IN PARTICULAR AS KDR INHIBITORS
ITFI20050041A1 (en) HYDROXAMMED AS INHIBITORS OF ISTONE DEACELITASIS, THEIR PREPARATION AND PHARMACEUTICAL FORMULATIONS THAT CONTAIN THEM
WO2009032843A3 (en) Deuterated ethambutols and their use
FR2907120B1 (en) NOVEL IMIDAZOLON DERIVATIVES, THEIR PREPARATION AS MEDICAMENTS, PHARMACEUTICAL COMPOSITIONS, USE AS PROTEIN INHIBITORS KINASES IN PARTICULAR CDC7
FR2920774B1 (en) NOVEL N-PHENUL ACATAMIDE DERIVATIVES, ENZYME INHIBITORS SOAT-1, PHARMACEUTICAL AND COSMETIC COMPOSITIONS CONTAINING THE SAME
EP2196463A4 (en) Preparation of 5,6-dimethylxanthone-4-acetic acid, the derivatives prepared and pharmaceutical formulations thereof
FR2888239B1 (en) NOVEL 2,4-DIANILINOPYRIMIDINE DERIVATIVES, THEIR PREPARATION AS MEDICAMENTS, PHARMACEUTICAL COMPOSITIONS AND IN PARTICULAR AS INHIBITORS OF IKK
FR2920769B1 (en) NOVEL N-PHENYL ACETAMIDE DERIVATIVES, ENZYME INHIBITORS SOAT-1, PHARMACEUTICAL AND COSMETIC COMPOSITIONS CONTAINING SAME

Legal Events

Date Code Title Description
ST Notification of lapse

Effective date: 20160729